Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
BPC 157- Reaction / Application on Synthetic Works Dec 9, 2019 Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory bowel disease clinical trials and wound healing, stable in human gastric juice and has no reported toxicity
Barbieri, M
Observed side effects in research settings may include: Nausea Temporary digestive discomfort Reduced appetite Bloating Constipation Fatigue Headaches Injection-site irritation Proper reconstitution, sterile handling practices, consistent administration protocols, hydration, electrolyte support, and adequate protein intake are important considerations during research use
Unregulated Source Risks Because IGF-1 LR3 is sold for research use only, product quality is inconsistent, increasing the risk of contamination or underdosing
Whelan, K., Bancil, A
With three generics on the market, Tadrous projected the price could drop to about $100 per month or less, depending on dose
